What does an RDW of 14.9% indicate and what are the recommended next steps for evaluation and management?

RDW 14.9%: Clinical Significance and Management

An RDW of 14.9% is at the upper limit of normal and warrants evaluation of the complete blood count, particularly MCV and hemoglobin, along with serum ferritin to assess for iron deficiency or combined nutritional deficiencies.

What This Value Indicates

An RDW of 14.9% reflects mild heterogeneity in red blood cell size (anisocytosis). While the normal reference range is typically 11.6-14.6%, this value sits just above the threshold and requires clinical context:

Primary Diagnostic Considerations

Combined nutritional deficiencies are the most important consideration at this RDW level. A raised RDW may indicate combined deficiency (e.g., iron plus folate deficiency) even when microcytosis is absent, as the two deficiencies can mask each other's typical MCV changes 1.

Iron deficiency should be evaluated first:

• Check serum ferritin (the most powerful test for iron deficiency)
• Ferritin <12 μg/dL is diagnostic of iron deficiency
• Ferritin >100 μg/dL essentially excludes iron deficiency
• Values between 12-100 μg/dL require clinical judgment, especially with concurrent inflammation, malignancy, or liver disease 1

Additional Differential Considerations

• Early or evolving anemia where RDW rises before other parameters become abnormal
• Thalassemia trait (though typically presents with elevated red cell count)
• Anemia of chronic disease (may present with microcytosis and elevated RDW)
• Hemoglobinopathies in certain ethnic groups (requires laboratory confirmation) 1

Recommended Next Steps

Immediate Laboratory Evaluation

1. Review the complete CBC parameters:

   • Hemoglobin and hematocrit levels
   • MCV (mean corpuscular volume)
   • Red blood cell count
   • Platelet count

2. Order serum ferritin as the initial diagnostic test 1

3. Consider additional iron studies if ferritin is equivocal:

   • Transferrin saturation (<30% supports iron deficiency)
   • Consider therapeutic trial of oral iron for 3 weeks if diagnosis remains uncertain 1

4. Evaluate for combined deficiencies:

   • Vitamin B12 level
   • Folate level
   • Reticulocyte count

Clinical Assessment

Obtain targeted history focusing on:

• Dietary intake (iron, B12, folate sources)
• GI symptoms (though these rarely correlate with findings)
• NSAID or aspirin use
• Anticoagulant use
• Family history of thalassemia, sideroblastic anemia, or bleeding disorders
• Ethnic background (for hemoglobinopathy risk) 1

If Iron Deficiency is Confirmed

GI evaluation is mandatory unless there is clear non-GI blood loss:

• Upper GI endoscopy with small bowel biopsies (2-3% of iron deficiency anemia patients have celiac disease)
• Lower GI evaluation (colonoscopy preferred, especially in elderly patients)
• Both upper and lower GI tract examination recommended as dual pathology occurs in ~10% of cases 1

Prognostic Context

While this RDW value is only mildly elevated, it's important to note that RDW has emerged as a prognostic marker beyond anemia diagnosis. Higher RDW values (particularly >14-16%) are associated with increased mortality in cardiovascular disease, heart failure, sepsis, ARDS, and various malignancies 2, 3, 4, 5. However, at 14.9%, the primary focus should remain on identifying and treating any underlying nutritional deficiency or occult pathology.

Critical Pitfall to Avoid

Do not assume dietary insufficiency explains the findings without complete evaluation. Even with a positive dietary history suggesting borderline iron intake, full GI investigation is still required if iron deficiency is confirmed, as occult GI pathology (including malignancy) may be present 1.